Get a reply from this employer
Your resume and cover letter, tailored to exactly what they’re hiring for.
Convatec is seeking a Principal R&D Engineer to lead the Infusion Care R&D portfolio, directing customer projects and new product development in a highly regulated medical devices environment. The role focuses on Design Control, DHFs, and change control across a global portfolio, while mentoring peers and aligning with Operations, Quality, Regulatory, and Manufacturing.
You will drive data‑driven decisions, optimize R&D processes, and engage with cross‑functional teams to deliver
We’re looking for a Principal R&D Engineer to join our Infusion Care R&D team and play a key role in shaping the next generation of products and technologies. This is a highly visible technical leadership position where you’ll lead customer projects, new product development initiatives, and change control activities across a global portfolio of medical devices.
As we expand our focus beyond product remediation and into exciting new development opportunities, you’ll have the chance to influence product strategy, challenge existing ways of working, drive continuous improvement, and collaborate with cross‑functional teams across R&D, Operations, Quality, Regulatory, Commercial, and Manufacturing.
This role is ideal for someone who combines strong technical expertise with sound judgement, a proactive mindset, and the confidence to lead projects, make decisions, and influence stakeholders at all levels.
Convatec has announced a major milestone in our R&D journey and commitment to our vision ofpioneering trusted medical solutions to improve the lives we touch.We have unveiled plans to relocate the majority of our UK-based research and development (R&D) activities from Deeside to Manchester from late 2027/early 2028, alongside a significant expansion of our facilities in Boston.
The new, planned Manchester facility has the potential to be a major R&D hub in our global network which will initially function as the company’s global testing laboratories, with cutting‑edge analytical R&D capabilities including quality control and materials, regulatory functions, and health innovation, positioning Convatec at the forefront of medical technology development. Our new state‑of‑the‑art facilities will also strengthen our collaboration with Manchester’s vibrant life sciences ecosystem, which includes leading universities, hospitals, and research institutions.
Convatec provides equal employment opportunities for all current employees and applicants for employment. This policy means that no one will be discriminated against because of race, religion, creed, color, national origin, nationality, citizenship, ancestry, sex, age, marital status, physical or mental disability, affectional or sexual orientation, gender identity, military or veteran status, genetic predisposing characteristics or any other basis prohibited by law.
Convatec is not accepting unsolicited resumes from agencies and/or search firms for this job posting. Resumes submitted to any Convatec employee by a third party agency and/or search firm without a valid written and signed search agreement, will become the sole property of Convatec. No fee will be paid if a candidate is hired for this position as a result of an unsolicited agency or search firm referral. Thank you.
If you are an active employee at Convatec, please do not apply here. Go to the Career Worklet on your Workday home page and View “Convatec Internal Career Site - Find Jobs”. Thank you!
Pioneering trusted medical solutions to improve the lives we touch:
Convatec is a global medical products and technologies company, focused on solutions for the management of chronic conditions, with leading positions in Advanced Wound Care, Ostomy Care, Continence Care, and Infusion Care. With over 10,000 colleagues, we provide products and services in around 90 countries, united by a promise to be forever caring. Our solutions provide a range of benefits, from infection prevention, treatment for hard to heal wounds, at‑risk skin and ulcerated tissue to supporting debilitating conditions, improved patient outcomes and reduced care costs. Convatec’s revenues in 2025 were over $2 billion. The company is a constituent of the FTSE 100 Index (LSE:CTEC). To learn more please visit: http://www.convatecgroup.com.